GLP Matrix Eye 4

£2499.00

Fair Value

1 stores tracked

Buy Signal

Price near historical average — neutral outlook

Confidence: 50/100

RSI (14)

—

Need 15+ data points

Volatility (ann.)

—

Need more data

30d Momentum

—

Need 30+ data points

Price Position

—

No 90d range data

EMA 20

—

EMA 50

—

Need 50+ data points

90d Low / High

—

30d Forecast

—

→ Stable

◈ AI Recommendation EngineRule-based · v1

Fair Value

Price near historical average — neutral outlook

Confidence: 50%

Reasons to Buy

✓Detailed product specifications available — transparent product information

Risks / Watch Out

✗Only 1 store carrying this product — limited price competition

Product Fundamentals

GLP Matrix Eye 4
LED Blinder and Effect Light
For stage, events and outdoor
Light source: RGBAL LED, four engines with 50 LEDs each
White points 3,200 K
4,200 K
5,600 K
6,500 K
8,000 K
Variable CTC 2,500–10,000 K
Luminous flux: Up to 45,200 lm
Colour rendering (CRI): > 90 at 6,500 K
Beam angle: 60° Beam
100° Field
Display and operation: Backlit graphical LCD
4-button menu navigation
Tungsten simulation
Eight bit and 16 bit dimmer
Shutter FX
Individually adjustable head alignment ±20°
Pixel mirror functions
Control/dimming: DMX512-A
RDM
GLP iQ.Mesh
Power consumption: max. 2000 W
Supply voltage: 100–240 V AC
50/60 Hz
Protection rating: IP65
Housing material: Flame-retardant plastic, aluminium, steel
Mounting type: Truss mounting, standing, hanging
Power input and output: powerCON TRUE1
DMX input and output: XLR 5-pin
Dimensions with arm (W x D x H): 400 x 353 x 400 mm
Weight with yoke 400/200: 15.3 kg
Housing colour: Black
Includes user manual

◉ From Our Partner Storescached 1h

GLP Delivers Massive Punch At Sabaton’s Gamescom 2025 Performance - Live Design Online

Live Design Online· 24d ago

Unlocking the potential of GLP-1 receptor agonists in ocular therapeutics: from molecular pathways to clinical impact - Frontiers

Frontiers· 277d ago

Several New Serums Promise to Reverse Weight Loss–Induced Sagging Skin. Can They Possibly Work? - Women's Health

Women's Health· 87d ago

Preclinical safety and biodistribution of SPVN06, a novel gene- and mutation-independent gene therapy for rod-cone dystrophies - Nature

Nature· 265d ago

Topical and systemic GLP-1R agonist administration both rescue retinal ganglion cells in hypertensive glaucoma - Frontiers

Frontiers· 1053d ago

GearDeals Intelligence · Data from 0 historical price points · Analysis is informational only, not financial advice